Jalen Hurts Out for Season With Blood Clots in Both Lungs, Eagles Super Bowl Odds Plunge
Jalen Hurts has been diagnosed with deep vein thrombosis and blood clots in both lungs, ending his 2026 season and leaving the 2-4 Eagles with Tanner McKee and long odds.

Jalen Hurts will not play again this season. The Philadelphia Eagles and the quarterback’s agent, Nicole Lynn, confirmed in a joint statement Monday that additional testing revealed deep vein thrombosis and bilateral pulmonary emboli, meaning blood clots in both of his lungs, and reports from NFL Network and ESPN say the recovery will take at least three months.
The diagnosis is a stunning escalation for a franchise that already looked shaky. Hurts, a Super Bowl LIX MVP who led Philadelphia to a championship during the 2024 season, entered 2026 as the engine of an Eagles offense that has now lost its quarterback, its right tackle and, for long stretches, its star running back. The news landed hard enough that Hurts was among the top trending names on X on Monday, with fans flooding the platform with messages of support.
How a Calf Injury Became a Season-Ending Diagnosis
The timeline moved quickly. Hurts took a cleat to the calf in Week 4, and a follow-up ultrasound the next Thursday revealed a blood clot in his leg. Initially, the Eagles described it as a superficial clot. Doctors in London reportedly told him to avoid sleep as a precaution ahead of the Week 5 game against the Jacksonville Jaguars, and according to NFL insider Tom Pelissero, Hurts was awake for roughly 36 hours when he took the field. He still threw for 220 yards and a touchdown while Saquon Barkley and DeVonta Smith were both sidelined.
Philadelphia placed him on injured reserve Saturday after the clot in his calf moved, which ruled him out for at least four games. Monday’s update revealed the scarier reality: the clot had traveled to his lungs. Per the statement, Hurts is clinically stable, has no significant functional limitations, and the team expects a full recovery. His treatment centers on blood thinners, and he is barred from contact activities, including football, while he receives it. In the statement, his agent said Hurts’ prognosis is very good.
Before the diagnosis, Hurts had completed 57.8 percent of his passes for 933 yards, eight touchdowns and three interceptions, adding 107 rushing yards and a score on the ground.
Eagles Turn to Tanner McKee as Playoff and Super Bowl Odds Crater
The immediate answer under center is Tanner McKee, who made his first start of the season in Sunday’s loss to the Carolina Panthers. It was not an encouraging debut. McKee completed 26 of 45 passes for 215 yards and one touchdown, and managed only a single completion of more than 15 air yards. The loss dropped Philadelphia to 2-4 after a 2-0 start.
The depth behind him is thin. Veteran Andy Dalton was released and then declined an offer to return. Instead, the Eagles signed former Cowboys practice-squad passer Joe Milton III, a move that flipped the Panthers line before the weekend. Rookie Cole Payton is also on the roster. Reports have suggested general manager Howie Roseman has explored McKee’s trade value in the past, so the front office may weigh outside help before the trade deadline, more than three weeks away.
The betting market reacted immediately. According to Sports Illustrated, Philadelphia’s Super Bowl odds have drifted from +4000 to +15000 over the past two weeks, and the Eagles are now +460 to make the playoffs. DraftKings Sportsbook moved them to +550 to win the NFC East, which is now the fourth-best price in the division. Bettors tracking these shifts can compare lines through the latest DraftKings promo code offer, but the bigger story is how quickly Philadelphia’s ceiling has dropped.
What Comes Next for Philadelphia
The NFC East remains unusually winnable, which is the only reason this season is not a complete write-off. The New York Giants lead the division at 3-2-1 and are also playing without their starting quarterback, so the Eagles sit just behind in the standings despite their 2-4 record. Nick Sirianni’s team needs Barkley healthy, a stable offensive line and at least competent quarterback play to stay in the race.
There is also a long-term angle. A roughly three-month recovery would stretch into January, leaving Hurts a normal offseason to prepare for 2027. The team has said it expects him to recover fully, and doctors’ emphasis on blood thinners, rather than surgery, offers some reassurance. For now, the focus in Philadelphia shifts from title contention to damage control, and from Hurts’ availability to his health.
Next up for the Eagles is a chance to see whether McKee or Milton can steady an offense that has scored too little for too long. Whatever happens on the field, Hurts’ recovery is the story that matters most, and the football world is clearly pulling for him.
